Bibliographic Info
GuidelineMental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders, [3rd ed.].
Year of Publication2023
Issuing InstitutionWorld Health Organization
Recommendation
Status
Updated
Recommended against
Conditional
Certainty of evidence
Low
Dexamphetamine, methylphenidate and modafinil are not recommended for the treatment of cocaine or stimulant use disorders due to safety concerns.